Study on the Mechanism of Gut Microbiota Mediating Restless Legs Syndrome Through Iron Metabolism

Trial statusNot yet recruiting
Trial phaseNot listed
Trial typeObservational
Biological sexAll
Age18+
SponsorWenxia Jiang

About this trial

The goal of this observational study is to collect fecal and serum samples from patients with restless legs syndrome (RLS) and healthy controls for differential microbiota analysis to identify key bacterial species involved in the pathogenesis of RLS. Subsequently, metabolomic analysis will be performed on fecal and serum samples from RLS patients to identify key regulatory molecules in iron metabolism disorder pathways. Finally, correlation analysis will be used to determine which specific bacterial species and metabolites are involved in the pathogenesis of RLS. The main question it aims to answer is: i) Do RLS patients exhibit gut microbiota dysbiosis compared to healthy controls? ii) Which specific bacterial species and metabolites are linked to iron metabolism abnormalities and the pathogenesis of RLS?

Eligibility criteria

Qualifiers

≥18 years old;

The diagnostic criteria all meet the five diagnostic criteria for restless legs syndrome established by the International Committee for the Study of Restless Legs Syndrome (IRLSSG) (2014 revised version)

Disqualifiers

Suffering from serious physical illnesses, such as tumors, cardiovascular diseases, diabetes, stroke, etc.;

Drug abuse, alcoholism, acute poisoning;

Antibiotic use within the 4 weeks preceding sampling;

Arobiotics or prebiotics use within the 4 weeks preceding sampling;

Trial design

Treatments tested in this trial

  • Not applicable- observational study

Treatment groups

No treatment groups listed

Locations

This trial has no locations

Sponsors and collaborators

Wenxia Jiang

Lead sponsor

Chongqing Traditional Chinese Medicine Hospital

Sponsor institution